this findings adds vs these findings add

Some examples from the web:

• If you add these findings to the stress fractures and numerous avulsion fractures...
• Other data sets have not confirmed this finding.
• This finding is not clinically relevant to man.
• Poland has not disputed this finding.
• This finding is confirmed by the data available in the second quarter of 2003.
• This finding is confirmed after careful consideration of the disclosure submissions.
• This finding has not been disputed by any party concerned.
• This finding was accepted by the Valuation Tribunal in the case at hand.
• The parties concerned did not provide any information which could have devaluated this finding.
• The interested parties did not provide any evidence which could have devaluated this finding.
• The interested parties did not provide any evidence which could have devaluated this finding.
• This finding applies equally to compliance with the provisions set out in the Eighth Report on Competition Policy.
• The information available to the Authority confirms this finding.
• This finding is confirmed by the fact that the related importers incurred significant financial losses during the IP.
• We published a paper that described this finding at the earliest prototype stage.
• The relevance of this finding is unknown.
• The significance of this finding is being further studied.
• This finding is compatible with the short half-life of melatonin in humans.
• The relevance of this finding for the therapeutic use in patients can not be excluded.
• The clinical relevance of this finding has not been determined.

Some examples from the web:

• If you add these findings to the stress fractures and numerous avulsion fractures...
• No compelling evidence has been submitted against these findings.
• No evidence was submitted which contradicted these findings.
• These findings are considered of low human relevance.
• These findings are expected effects of fluoropyrimidine derivatives.
• These findings confirm the results of earlier FVO missions.
• The relevance of these findings in relation to human health cannot be assessed at present.
• The restricted access decree follows up on these findings.
• No new evidence was provided which could alter these findings.
• No substantiated evidence has been provided in this investigation as to disprove these findings.
• These findings can vary in severity and may occur simultaneously.
• The classification of these findings is subjective according to the interpretation of the investigator.
• The party did not provide any evidence which could have devaluated these findings.
• These findings are not called into question by the submissions from competitors.
• The company disputed some of these findings.
• No more detailed public service reports which led to these findings could however be accessed.
• Several interested parties made written submissions making their views known on these findings.
• First of all, these findings relate to a period different from the IP.
• The Council confirms these findings, and those in recital 55 of the provisional Regulation.
• Where possible and justified, these findings were subsequently compared with the data for the captive market.